AI assistant
Sending…
MCCORMICK & CO INC — Director's Dealing 2023
Mar 16, 2023
30330_dirs_2023-03-16_6e352ac7-fd53-487e-9345-d878e89db2b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MCCORMICK & CO INC (MKC)
CIK: 0000063754
Period of Report: 2023-03-15
Reporting Person: HRABOWSKI FREEMAN A III (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-15 | Common Stock - Voting | M | 1044 | — | Acquired | 102852.835 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-15 | Restricted Stock Units | $ | M | 1044 | Disposed | Common Stock - Voting (1044) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock - Non Voting | 5133.246 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Stock | $ | Common Stock - Voting (0) | 25480.148 | Indirect |
Footnotes
F1: Subject to deferred receipt.
F2: Restricted Stock Units; No purchase price required.
F3: Each share of phantom stock represents the right to receive one share of Common Stock - Voting. Shares of Phantom Stock are payable in shares of Common Stock - Voting in accordance with the terms of the Non-Qualified Retirement Savings Plan.
F4: The reported Restricted Stock Units entitles the Reporting Person to receive an annual distribution of common stock equal to 100% of the grant.
F5: Restricted Stock Units granted on March 30, 2022.
More from MCCORMICK & CO INC
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 1
Interim / Quarterly Report
2026
Mar 31
Regulatory Filings
2026
Mar 31